Blebbishield emergency program
Blebbishield Emergency Program is a cellular process that is activated in response to stress or damage, leading to the formation of blebbishields. These structures are protective and help the cell to survive under adverse conditions. The Blebbishield Emergency Program is particularly relevant in the context of cancer cells, where it can contribute to chemoresistance and tumor recurrence.
Overview[edit]
The Blebbishield Emergency Program is a survival mechanism that is activated in cells under stress. This process involves the formation of blebbishields, which are large, spherical structures that form from the plasma membrane. These structures are filled with cellular contents and are thought to protect the cell from damage.
Role in Cancer[edit]
In cancer cells, the Blebbishield Emergency Program can be activated in response to chemotherapy. This can lead to the formation of blebbishields, which protect the cancer cells and allow them to survive the treatment. This can contribute to chemoresistance, where the cancer cells are able to resist the effects of chemotherapy, and can lead to tumor recurrence.
Mechanism[edit]
The exact mechanism of the Blebbishield Emergency Program is not fully understood. However, it is thought to involve a number of cellular processes, including autophagy, apoptosis, and necrosis. These processes are all involved in cell death, and the activation of the Blebbishield Emergency Program is thought to prevent this from occurring.
Research[edit]
Research into the Blebbishield Emergency Program is ongoing, with the aim of developing new treatments for cancer. By understanding how this process works, it may be possible to develop drugs that can inhibit the formation of blebbishields, thereby making cancer cells more susceptible to chemotherapy.
See Also[edit]
References[edit]
<references />
-
BS-Fig1
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
